The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell
- PMID: 11070168
- DOI: 10.1016/s1074-7613(00)00049-2
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell
Abstract
Epstein-Barr virus-infected B cells in vivo demonstrate three distinct patterns of latent gene expression, depending on the differentiation stage of the cell. Tonsillar naive B cells express the EBNA2-dependent lymphoblastoid phenotype, characteristic of direct infection. Germinal center centroblasts and centrocytes as well as tonsillar memory B cells express a more restricted pattern of latent genes (EBNA1(Q-K)+, LMP1+, LMP2+, EBNA2-) that has only been seen previously in EBV-positive tumors. Peripheral memory cells express an even more restricted pattern where no latent genes are expressed, with the possible exception of LMP2. These results are consistent with a model where EBV uses the normal biology of B lymphocytes to gain access to and persist within the long-lived memory B cell compartment.
Similar articles
-
EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency.Immunity. 2000 Oct;13(4):485-95. doi: 10.1016/s1074-7613(00)00048-0. Immunity. 2000. PMID: 11070167
-
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):239-44. doi: 10.1073/pnas.2237267100. Epub 2003 Dec 19. Proc Natl Acad Sci U S A. 2004. PMID: 14688409 Free PMC article.
-
Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils.J Virol. 2000 Nov;74(21):9964-71. doi: 10.1128/jvi.74.21.9964-9971.2000. J Virol. 2000. PMID: 11024124 Free PMC article.
-
Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Eur J Cell Biol. 2012. PMID: 21450364 Review.
-
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Autoimmunity. 2008. PMID: 18432410 Review.
Cited by
-
Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice.Front Immunol. 2021 Mar 23;12:640918. doi: 10.3389/fimmu.2021.640918. eCollection 2021. Front Immunol. 2021. PMID: 33833760 Free PMC article. Review.
-
Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.Blood. 2013 Feb 28;121(9):1584-94. doi: 10.1182/blood-2012-08-450775. Epub 2013 Jan 7. Blood. 2013. PMID: 23297134 Free PMC article.
-
Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder.Pediatr Transplant. 2012 May;16(3):220-9. doi: 10.1111/j.1399-3046.2012.01656.x. Epub 2012 Feb 21. Pediatr Transplant. 2012. PMID: 22353174 Free PMC article. Review.
-
Effects of IRF5 lupus risk haplotype on pathways predicted to influence B cell functions.J Biomed Biotechnol. 2012;2012:594056. doi: 10.1155/2012/594056. Epub 2012 Feb 22. J Biomed Biotechnol. 2012. PMID: 22500098 Free PMC article.
-
Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.Cell Immunol. 2015 Oct;297(2):108-19. doi: 10.1016/j.cellimm.2015.08.001. Epub 2015 Aug 4. Cell Immunol. 2015. PMID: 26255694 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources